| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$36 |
Successful Resources Exec & Geologist Tim Laneyrie Appointed
|
19 Mar 2026 8:38AM |
$0.640 |
$0.730 |
risen by
14.06%
|
|
GR8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Tim Laneyrie appointed as Executive Director of Great Dirt Resources Ltd.
- Sam Brooks appointed as Consulting Geologist.
- Great Dirt Resources is expanding its exploration and acquisition activities.
- Tim Laneyrie has experience in mining and executive roles, including successful M&A transactions.
- Great Dirt has changed its registered office to West Perth, WA, effective 1 April 2026.
- Sam Wright has resigned from the board, effective 1 April 2026.
- Great Dirt is undertaking systematic, modern geochemical and geophysical surveys for manganese exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$36 |
Wombat-5 - Production Testing Continuing
|
19 Mar 2026 8:34AM |
$0.965 |
$0.495 |
fallen by
48.70%
|
|
LKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lakes Blue Energy NL (ASX:LKO) is conducting production testing at the Wombat-5 gas well.
- Wombat-5 encountered three strong gas zones within a 1,500 meter horizontal section.
- Operations focused on unloading drilling fluid using nitrogen lifting and conducting gas inflow pressure build-up testing.
- Additional operations are needed to establish full gas flow from the wellbore.
- The company has suspended well flow and cleanup activities and has demobilized contractor equipment.
- An extended pressure build-up phase has started, expected to provide long-term pressure buildup data.
- A perforation program is planned to improve gas flow into the wellbore, subject to regulatory approval.
- Technical design work and discussions with regulators for the next phase of operations are underway.
- The Wombat Field is still considered prospective for commercial gas production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$5 |
Update - Proposed issue of securities - CHM
|
19 Mar 2026 8:34AM |
$0.002 |
$0.100 |
risen by
4,900%
|
|
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$222 |
Change of Director's Interest Notice - J Welborn
|
19 Mar 2026 8:32AM |
$0.335 |
$0.290 |
fallen by
13.43%
|
|
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$17 |
Investor Presentation
|
19 Mar 2026 8:31AM |
$0.200 |
$0.200 |
fallen by
0%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,770 |
Net Tangible Asset Backing
|
19 Mar 2026 8:28AM |
$4.010 |
$4.370 |
risen by
8.98%
|
|
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$650 |
Dateline acquires additional drill rig for REE drilling
|
19 Mar 2026 8:28AM |
$0.505 |
$0.170 |
fallen by
66.34%
|
|
| Galileo Mining Ltd (GAL) ORDINARY FULLY PAID |
Materials |
$24 |
Highly Prospective PGE Sulphides in Norseman Drilling
|
19 Mar 2026 8:27AM |
$0.165 |
$0.120 |
fallen by
27.27%
|
|
GAL - Price-sensitive ASX Announcement
Full Release
Key Points
- One metre split assays from December RC drill campaign show consistent zones of anomalous palladium-platinum-copper-nickel sulphides at the Mission Sill prospect.
- Disseminated sulphide zones are open along strike and at depth with potential for higher grades.
- PGE drill results from shallow sulphide zones in fresh rock include significant findings.
- Mineralisation at Mission Sill occurs within discrete intrusions similar to the Callisto resource.
- Diamond core drilling beneath the Callisto resource has been completed.
- Galileo Mining Ltd holds 100% ownership of Norseman project, comprising multiple mining leases and exploration licenses.
- Additional RC and aircore drill programs are planned to refine the PGE target horizon.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$5 |
Consolidation/Split - CHM
|
19 Mar 2026 8:26AM |
$0.002 |
$0.100 |
risen by
4,900%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Security consolidation of ordinary shares and options by Chimeric Therapeutics Limited.
- Consolidation ratio of 100 to 1.
- Effective date of consolidation is April 20, 2026.
- Post-consolidation trading commences on April 22, 2026.
- Record date for consolidation is April 23, 2026.
- Final settlement of trades on May 5, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$203 |
Quarterly Cash Flow Report
|
19 Mar 2026 8:25AM |
$0.690 |
$0.450 |
fallen by
34.78%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Increased research and development spending due to post-approval study enrolment
- Higher advertising and marketing costs for commercialization
- Elevated administration costs from prepayment of annual insurance premiums
- Negative net cash flow from operating activities
- Significant expenditures in research, manufacturing, marketing, and administration
- Net outflow from investing activities due to equipment acquisitions
- Substantial positive cash flow from financing activities from equity securities
- End period cash position significantly bolstered
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$222 |
Cleansing Notice
|
19 Mar 2026 8:25AM |
$0.335 |
$0.290 |
fallen by
13.43%
|
|
| IVE Group Limited (IGL) ORDINARY FULLY PAID |
Communication Services |
$392 |
Update - Notification of buy-back - IGL
|
19 Mar 2026 8:24AM |
$2.640 |
$2.550 |
fallen by
3.41%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,598 |
Update - Notification of buy-back - MFG
|
19 Mar 2026 8:23AM |
$10.450 |
$8.600 |
fallen by
17.70%
|
|
| Temple & Webster Group Ltd (TPW) ORDINARY FULLY PAID |
Consumer Discretionary |
$602 |
Update - Notification of buy-back - TPW
|
19 Mar 2026 8:23AM |
$6.660 |
$5.060 |
fallen by
24.02%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,036 |
Update - Notification of buy-back - ZIP
|
19 Mar 2026 8:22AM |
$1.560 |
$2.420 |
risen by
55.13%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$421 |
Update - Notification of buy-back - CGS
|
19 Mar 2026 8:22AM |
$2.200 |
$2.460 |
risen by
11.82%
|
|
| EDU Holdings Limited (EDU) ORDINARY FULLY PAID |
Consumer Discretionary |
$122 |
Update - Notification of buy-back - EDU
|
19 Mar 2026 8:22AM |
$0.680 |
$0.980 |
risen by
44.12%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$241 |
IMB Change in Shareholding - Director Associated
|
19 Mar 2026 8:22AM |
$0.525 |
$0.585 |
risen by
11.43%
|
|
| Oohmedia Limited (OML) ORDINARY FULLY PAID |
Communication Services |
$713 |
Update - Notification of buy-back - OML
|
19 Mar 2026 8:22AM |
$0.950 |
$1.350 |
risen by
42.11%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,550 |
Update - Notification of buy-back - ORA
|
19 Mar 2026 8:21AM |
$1.970 |
$1.265 |
fallen by
35.79%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$418 |
Update - Notification of buy-back - RG8
|
19 Mar 2026 8:21AM |
$2.640 |
$2.910 |
risen by
10.23%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$241 |
IMB Form 604 - Black Crane
|
19 Mar 2026 8:21AM |
$0.525 |
$0.585 |
risen by
11.43%
|
|
| Objective Corporation Limited (OCL) ORDINARY FULLY PAID |
Information Technology |
$1,105 |
Update - Notification of buy-back - OCL
|
19 Mar 2026 8:21AM |
$12.240 |
$11.510 |
fallen by
5.96%
|
|
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$203 |
2025 Activity Report and Form 10-K submission
|
19 Mar 2026 8:21AM |
$0.690 |
$0.450 |
fallen by
34.78%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA approved EBR's WiSE CRT System in April 2025 for commercial distribution in the U.S.
- The company achieved significant milestones in 2025, transitioning from a developmental stage to a commercial medical device business.
- EBR successfully completed a capital raise of A$79.5 million in Q2 2025.
- Despite growth, substantial doubt exists about EBR's ability to continue as a going concern due to ongoing financial losses.
- EBR has been focusing on expanding its commercial reach and has seen early success with its WiSE CRT System implants.
- The company secured reimbursement pathways through U.S. Medicare approvals, enhancing market adoption potential.
- EBR initiated clinical studies like WiSE-UP and TLC-AU to support long-term growth and evidence generation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$549 |
Update - Notification of buy-back - RG1
|
19 Mar 2026 8:21AM |
$2.190 |
$2.310 |
risen by
5.48%
|
|